Coiante Scott M 4
4 · Aprea Therapeutics, Inc. · Filed Mar 14, 2022
Insider Transaction Report
Form 4
Coiante Scott M
SVP, Chief Financial Officer
Transactions
- Award
Common Stock
2022-03-10+42,900→ 119,549 total - Award
Stock Option (right to Buy)
2022-03-10+185,900→ 185,900 totalExercise: $1.82Exp: 2032-03-10→ Common Stock (185,900 underlying)
Footnotes (2)
- [F1]These shares represent restricted stock units which were granted on March 10, 2022, and which will vest and be settled in common stock as follows: (i) 14,300 shares on March 10, 2023, (ii) 14,300 shares on March 10, 2024 and (iii) 14,300 shares on March 10, 2025, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions.
- [F2]Twenty-five percent of these options vest on March 10, 2023, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions.